This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Roche Diagnostics Seattle, Inc., Roche Sequencing Solutions, Inc.. Active years: 2024-2026.
Company Filing History:

Years Active: 2024-2026
Title: Lacey Merrill: Innovator in Nucleic Acid Polymerization
Introduction
Lacey Merrill is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of nucleic acid polymerization, particularly in enhancing DNA replication processes. Her innovative work has implications for advanced sequencing technologies.
Latest Patents
Lacey Merrill holds a patent titled "Enhancement of nucleic acid polymerization by aromatic compounds." This invention relates to compounds, methods, and compositions that improve nucleic acid polymerization, including DNA replication through in vitro primer extension. The technology aims to generate polymers suitable for nanopore-based single molecule sequencing of DNA templates. The nucleic acid polymerase reaction composition she developed includes polymerization enhancement moieties, which enhance DNA polymerase activity with nucleotide analogs. This results in improved lengths of primer extension products, making it valuable for sequencing applications. She has 1 patent to her name.
Career Highlights
Throughout her career, Lacey has worked with notable companies in the biotechnology sector. She has been associated with Roche Sequencing Solutions, Inc. and Roche Diagnostics GmbH, where she contributed her expertise in nucleic acid technologies. Her work has been instrumental in advancing the capabilities of DNA sequencing.
Collaborations
Lacey has collaborated with several professionals in her field, including Mark Stamatios Kokoris and John Tabone. These collaborations have further enriched her research and development efforts.
Conclusion
Lacey Merrill is a trailblazer in the field of nucleic acid polymerization, with a focus on enhancing DNA replication technologies. Her innovative patent and contributions to leading biotechnology companies underscore her impact on the industry.